An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these profiles privately for source information, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” images, injection guides and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Voice Worries
However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.
Some professionals stated the popularity for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.
Service Response and Material Removal
Based on TikTok, the service has taken down problematic material and prohibited associated keywords and search suggestions. The company said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.
Digital Trading Operations
Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of slimming results, glowing reviews and step-by-step guides for mixing or administering at home.
After moments of entering one community, a vendor shared contact information, where the majority of transactions occur. The seller sent an guidebook and promised shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or past usage.
Product Information and Pricing
Within these communities, posts display dark colored packages with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Safety Measures
A representative for the messaging service said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has previously seen patients injured by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may subject users to potentially serious health risks”.
